Literature DB >> 31256363

A retrospective study of malignant melanoma from a tertiary care centre in Saudi Arabia from 2004 to 2016.

A Alshedoukhy1, P Cahusac2,3, J Kashir3,4,5, F H Alkhawaja6, A M M Tulbah7, K Anwar8.   

Abstract

BACKGROUND: Malignant melanoma is a well-known and commonly lethal tumour yet there exists scarce published information available from Saudi Arabia.
MATERIALS AND METHODS: This study examined the demographic, clinical, and histopathological profile of melanoma in a sample of Saudi patients over a period of 13 years. Medical records of 98 patients from 2004 to 2016 were retrieved from the Department of Pathology and Laboratory Medicine at King Faisal Specialist Hospital (KFSH), Riyadh, Saudi Arabia.
RESULTS: Forty two males and fifty six females (median age of 58 years) were analysed. Most cases were diagnosed in patients aged 50 years or above. The most common sites of occurrence were the extremities, especially the feet, followed by the head and neck, and then mucosal regions. Most mucosal melanomas were located in the mouth. The most common histopathological form was nodular melanoma (38 cases) followed by acral lentiginous melanoma (27 cases). Most of the cases were diagnosed in late diagnostic stages III and IV (59 cases) and most had higher Clark's level and stage V Breslow thickness. The cases with preceding history of xeroderma pigmentosum and dysplastic nevi tended to be diagnosed earlier. The most common mode of treatment was surgical resection. Patients on palliative treatment were older. Only 27/40 patients were confirmed to be alive and the rest were lost to follow-up.
CONCLUSION: Our data contrast with previously published studies from other parts of the world. Further work is needed to confirm our findings of female preponderance, common histological subtypes of nodular and acral melanomas, and the high involvement of oral mucosa in our Saudi patients.

Entities:  

Keywords:  Clinicopathological correlation; Malignant melanoma; Saudi Arabia

Mesh:

Year:  2019        PMID: 31256363     DOI: 10.1007/s12094-019-02169-w

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.340


  22 in total

Review 1.  Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification.

Authors:  Marco Rastrelli; Saveria Tropea; Carlo Riccardo Rossi; Mauro Alaibac
Journal:  In Vivo       Date:  2014 Nov-Dec       Impact factor: 2.155

2.  Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation.

Authors:  Daniel T Chang; Robert J Amdur; Christopher G Morris; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-12       Impact factor: 7.038

3.  Combined-modality therapy for patients with regional nodal metastases from melanoma.

Authors:  Matthew T Ballo; Merrick I Ross; Janice N Cormier; Jeffrey N Myers; Jeffrey E Lee; Jeffrey E Gershenwald; Patrick Hwu; Gunar K Zagars
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-22       Impact factor: 7.038

Review 4.  Dysplastic nevi and malignant melanoma.

Authors:  W A Crutcher; P J Cohen
Journal:  Am Fam Physician       Date:  1990-08       Impact factor: 3.292

5.  A retrospective multicenter evaluation of cutaneous melanomas in Turkey.

Authors:  Mehmet Gamsizkan; Ismail Yilmaz; Nesimi Buyukbabani; Cuyan Demirkesen; Murat Demiriz; Emel Dikicioglu Cetin; Umit Ince; Taner Akalin; Nese Calli Demirkan; Banu Lebe; Ozlem Erdem; Ozay Gokoz; Damlanur Sakiz; Peyker Temiz Demireli; Hesna Muzeyyen Astarci; Saduman Balaban Adim; Itir Ebru Zemheri; Arbil Acikalin; Banu Yaman; Ovgu Aydin; Cumhur Ibrahim Bassorgun
Journal:  Asian Pac J Cancer Prev       Date:  2014

6.  Influence of age on survival in childhood spitzoid melanomas.

Authors:  Marlyanne Pol-Rodriquez; Shing Lee; David N Silvers; Julide Tok Celebi
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860

7.  Histologic criteria for diagnosing primary cutaneous malignant melanoma.

Authors:  Bruce R Smoller
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

Review 8.  Complete metastasectomy in patients with stage IV metastatic melanoma.

Authors:  David W Ollila
Journal:  Lancet Oncol       Date:  2006-11       Impact factor: 41.316

9.  Why do melanomas ulcerate?

Authors:  J M Mascaro; J Castro; T Castel; M Lecha; R Gratacos; J M Mascaro
Journal:  J Cutan Pathol       Date:  1984-08       Impact factor: 1.587

Review 10.  Xeroderma pigmentosum.

Authors:  Alan R Lehmann; David McGibbon; Miria Stefanini
Journal:  Orphanet J Rare Dis       Date:  2011-11-01       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.